Medpace Hldgs Q4 EPS $2.46 Beats $2.22 Estimate, Sales $498.40M Miss $498.71M Estimate
Portfolio Pulse from Happy Mohamed
Medpace Holdings (MEDP) reported Q4 earnings of $2.46 per share, surpassing the $2.22 estimate, marking a 16.04% increase from last year. However, their Q4 sales of $498.40M slightly missed the $498.71M estimate, despite being a 26.47% increase from the previous year.
February 12, 2024 | 9:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medpace Holdings reported higher than expected Q4 earnings but slightly missed sales estimates. Earnings per share were $2.46, beating the $2.22 estimate, with a 16.04% YOY increase. Sales were $498.40M, just below the $498.71M estimate, yet marked a 26.47% YOY growth.
The positive earnings surprise and year-over-year growth in both earnings and sales indicate strong financial health and operational efficiency, likely leading to a positive short-term impact on MEDP's stock price. The slight miss on sales estimates is minor and unlikely to significantly dampen investor sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100